10 Best Multibagger Penny Stocks to Buy According to Billionaires

5. Clover Health Investments, Corp. (NASDAQ:CLOV)

Number of Billionaire Holders: 7

1-Year Gain as of April 21: 480.65%

Share Price as of April 21: $3.60

Clover Health Investments, Corp. (NASDAQ:CLOV) is a healthcare company that provides Medicare Advantage plans. Using a data-driven approach, it offers preferred provider organization and health maintenance organization plans to Medicare-eligible individuals. The stock has rallied by about 480.65% over the past year as investors react to a significant growth in its Medicare Advantage membership.

While membership has surpassed the 100,000 level, Clover Health Investments, Corp. (NASDAQ:CLOV) has also seen its flagship PPO plan upgraded with a 4-star rating by the Centers for Medicare and Medicaid Services. The robust membership growth was the catalyst behind the company delivering a 9% increase in insurance revenue to $1.3 billion. Clover Health achieved profitability in full-year 2024, with EBITDA rising by $112 million to reach $70 million.

Clover Health Investments, Corp. (NASDAQ:CLOV) expects the underlying growth to continue in 2025 as it projects a 30% year-over-year increase in Average Medicare Advantage membership. It also expects insurance revenue to be between $1.8 and $1.875 billion. On April 8, Canaccord Genuity reaffirmed a Buy rating and a $4.50 price target for Clover Health (NASDAQ:CLOV), citing strong growth prospects and sector sentiment improvement. Clover Health’s robust performance, boosted by 4-Star rating reimbursements and revenue growth, positions it well for future expansion in 2026.